Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
35.18
-2.17 (-5.81%)
Mar 31, 2025, 9:45 AM EDT - Market open
Revolution Medicines Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$67.77
Upside
+92.64%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $72 → $73 | Strong Buy | Maintains | $72 → $73 | +107.50% | Mar 3, 2025 |
Stifel | Stifel | Strong Buy Maintains $80 → $78 | Strong Buy | Maintains | $80 → $78 | +121.72% | Feb 27, 2025 |
Needham | Needham | Strong Buy Maintains $60 → $59 | Strong Buy | Maintains | $60 → $59 | +67.71% | Feb 27, 2025 |
UBS | UBS | Strong Buy Maintains $65 → $71 | Strong Buy | Maintains | $65 → $71 | +101.82% | Jan 8, 2025 |
Wedbush | Wedbush | Buy Maintains $70 → $67 | Buy | Maintains | $70 → $67 | +90.45% | Dec 6, 2024 |
Needham | Needham | Strong Buy Maintains $68 → $62 | Strong Buy | Maintains | $68 → $62 | +76.24% | Dec 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $64 → $72 | Strong Buy | Maintains | $64 → $72 | +104.66% | Dec 4, 2024 |
Guggenheim | Guggenheim | Strong Buy Maintains $82 → $87 | Strong Buy | Maintains | $82 → $87 | +147.30% | Dec 3, 2024 |
Needham | Needham | Strong Buy Reiterates $68 | Strong Buy | Reiterates | $68 | +93.29% | Dec 3, 2024 |
JP Morgan | JP Morgan | Buy Maintains $63 → $71 | Buy | Maintains | $63 → $71 | +101.82% | Dec 3, 2024 |
Wedbush | Wedbush | Buy Maintains $59 → $70 | Buy | Maintains | $59 → $70 | +98.98% | Nov 7, 2024 |
Needham | Needham | Strong Buy Maintains $61 → $68 | Strong Buy | Maintains | $61 → $68 | +93.29% | Nov 7, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $62 → $64 | Strong Buy | Maintains | $62 → $64 | +81.92% | Nov 7, 2024 |
JP Morgan | JP Morgan | Buy Maintains $54 → $63 | Buy | Maintains | $54 → $63 | +79.08% | Nov 7, 2024 |
Piper Sandler | Piper Sandler | Buy Maintains $57 → $70 | Buy | Maintains | $57 → $70 | +98.98% | Nov 7, 2024 |
Guggenheim | Guggenheim | Strong Buy Maintains $72 → $82 | Strong Buy | Maintains | $72 → $82 | +133.09% | Oct 28, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.